Lijenta- MX 2.5 Tablet: Each extended release tablet contains Linagliptin INN 2.5 mg and Metformin Hydrochloride BP 1000 mg.
Lijenta- MX 5 Tablet: Each extended release tablet contains Linagliptin INN 5 mg and Metformin Hydrochloride BP 1000 mg.
Lijenta- MX is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Linagliptin and Metformin is appropriate.
